Senior Director, Business Development

Alpha-9 Oncology•Boston, MA

About The Position

Alpha-9 Oncology is seeking an experienced and strategic Senior Director, Business Development, to help drive investor relations and business development during an important stage of the company’s growth. Reporting to the Chief Financial Officer, this role identifies, evaluates, and executes strategic opportunities that advance the pipeline and create long-term value. The position maintains investor materials and tracking, develops the external partnership strategy, builds relationships across the biopharmaceutical industry, and leads transactions from initial opportunity through diligence, negotiation, and execution. This is a visible, hands-on role working closely with the CFO, Corporate Strategy, and leaders across Research, Clinical Development, CMC, Regulatory, Finance, Legal, and other functions. In an early-stage, collaborative organization, the Senior Director will have meaningful ownership and direct exposure to executive decision-making, helping shape Alpha-9’s strategic direction and growth as the company advances its pipeline. Alpha-9 Oncology is a clinical-stage biotechnology company pioneering radiopharmaceutical innovation for solid tumors. Its proprietary scaffolds use optimized binders, linkers, chelators, and radioisotopes to deliver targeted radiation to cancer cells while minimizing harm to surrounding healthy tissue. The company develops molecules using innovative targeting moieties and integrates imaging and therapeutic studies to support effective radiation delivery and improved patient outcomes. Its pipeline is entering clinical trials, supported by leading healthcare investors.

Requirements

  • Bachelor’s degree in Life Sciences, Business, or a related field.
  • At least 12 years of business development, corporate development, or strategic partnerships experience within the biotechnology or pharmaceutical industry.
  • Proven track record sourcing, structuring, negotiating, and closing biopharmaceutical transactions.
  • Experience with licensing, collaborations, strategic partnerships, and other forms of external innovation.
  • Strong understanding of drug development and the scientific, clinical, regulatory, and commercial factors that influence asset value.
  • Experience developing financial models and valuation analyses to support business development decisions.
  • Strong understanding of transaction structures, deal economics, and key business terms.
  • Demonstrated ability to lead complex negotiations and cross-functional diligence processes.
  • Strong strategic thinking and business judgment, with the ability to assess opportunities and make clear recommendations.
  • Excellent communication and relationship-building skills, including the ability to engage effectively with senior executives and external partners.
  • Highly collaborative, with the ability to operate independently in a lean, fast-paced environment.
  • Willingness to travel up to 20–30% as needed for partner meetings, conferences, and industry events.

Nice To Haves

  • Advanced degree such as a Ph.D., M.D., or MBA.

Responsibilities

  • Lead development and execution of the business development strategy in alignment with the pipeline, corporate strategy, and long-term growth objectives.
  • Identify, source, and cultivate licensing, collaboration, strategic partnership, and other transaction opportunities.
  • Evaluate opportunities across scientific, clinical, commercial, strategic, and financial dimensions, including competitive landscape, intellectual property, development potential, valuation, and strategic fit.
  • Build and maintain a network across biotechnology, pharmaceutical, academic, and other relevant organizations, representing Alpha-9 at conferences, partnering meetings, and other external events.
  • Lead cross-functional diligence with Research, Clinical Development, CMC, Regulatory, Finance, Legal, and other teams; coordinate external diligence and develop recommendations for executive leadership.
  • Lead business development transactions through opportunity assessment, diligence, structuring, negotiation, execution, and closing, in partnership with the CFO, Finance, Legal, and other stakeholders.
  • Develop transaction analyses, financial models, valuation assessments, and executive-level materials to support opportunity evaluation, transaction decisions, and corporate strategy.
  • Partner with the CFO and Director, Corporate Strategy & Chief of Staff to assess external opportunities in the context of portfolio priorities, corporate strategy, and long-term objectives.
  • Support management of strategic partnerships and collaborations to help ensure Alpha-9 meets its commitments and captures the intended value of transactions.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service